The results obtained using endothelin antagonists are particularly disappointing [27], and those using anti-TNFα (both monoclonal antibodies and soluble receptors) are surprisingly modest even if this cytokine represents the most important biochemical marker of inflammatory processes in CHF [28-30]. The gene discussed is TNF; the disease is congestive heart failure.